Day One Biopharmaceuticals, Inc vs Pfizer, Inc. — Stock Comparison
Q·Score Breakdown
4.5
Bearish
Overall
6.5
Neutral
Quality
Health
Growth
Valuation
Sentiment
DAWN
Clean balance sheet with low leverage (0.0× debt-to-equity).
⚠ currently unprofitable (-68% margin).
PFE
Strong profitability with 12% net profit margins.
⚠ analyst sentiment is cautious.
Analyst Consensus
HOLD
Target $21.50 (-0.1%)
6 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts
Fundamentals
DAWN
PFE
—
Trailing P/E
19.4×
-112.4×
Forward P/E
9.4×
-67.8%
Profit Margin
12.4%
89.1%
Gross Margin
75.8%
-22.7%
ROE
8.9%
83.9%
Revenue Growth
-1.2%
—
Earnings Growth
—
-1.75
Beta
0.39
—
Price / Book
—
$2.2B
Market Cap
$149.8B
$6 – $22
52-Week Range
$22 – $29
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →